In a nutshell This study investigated the rate of loco-regional recurrence (LRR) when breast-conserving surgery (BSC) was not followed by radiotherapy. This study concluded that the rate of LRR was low in patients who did not undergo radiation after BCS, but that age and margin width were risk factors for LRR. Some background BCS is a surgery...
Read More
In a nutshell This study compared the benefits of radiotherapy and tamoxifen in reducing the risk of local recurrence (return of the cancer close to initial place of origin) in patients with early breast cancer who underwent breast conserving surgery (BCS). Some background Women with early breast cancer usually have tumors that are confined...
Read More
The present review discusses the principles, methods and complications of breast reconstruction surgery for breast cancer patients who need mastectomy (surgical removal of the entire breast). Women with breast cancer often need extensive surgeries to eliminate the cancer, along with healthy breast tissue, skin or the nipple and areola (the darker area...
Read More
In a nutshell Tamoxifen treatment is given to many breast cancer patients after surgery to prevent recurrences and improve survival. It is usually given for a maximum of 5 years. This study determined that longer treatments offer further survival benefit. Some background Tamoxifen is a drug used against breast cancers which produce...
Read More
In a nutshell The risk of breast cancer is high (~80%) in women who inherit a damaged (mutated) gene called BRCA1 or BRCA 2 (‘BRCA carriers’). Following the first diagnosis, their risk of developing another tumor in the second breast within 10 years is 30%. Some background Some types of breast cancer need estrogen (female sex...
Read More
